America’s major medical society specializing in the treatment of respiratory diseases has endorsed using hydroxychloroquine for seriously ill hospitalized coronavirus patients.
The American Thoracic Society issued guidelines Monday that suggest COVID-19 patients with pneumonia get doses of the anti-malaria drug.
“To prescribe hydroxychloroquine (or chloroquine) to hospitalized patients with COVID-19 pneumonia if all of the following apply: a) shared decision-making is possible, b) data can be collected for interim comparisons of patients who received hydroxychloroquine (or chloroquine) versus those who did not, c) the illness is sufficiently severe to warrant investigational therapy, and d) the drug is not in short supply,” the Thoracic Society said.
This is an excerpt from the NY Post.
Recent Comments
Comment by Bluebird12345
Posted in New York lawmakers have deal to strip Cuomo of emergency COVID powers Mar 3, 08:01
Comment by Bluebird12345
Posted in Texas Governor lifts mask mandate, allows businesses to open at 100% Mar 3, 07:47
Comment by Jo
Posted in Elizabeth Warren says ‘it’s time’ for a wealth tax hike on ‘ultra-millionaires’ Mar 3, 06:33
Comment by ggfilthy
Posted in Dems ‘toying with something they don’t understand’ Mar 3, 05:54
Comment by ggfilthy
Posted in Elizabeth Warren says ‘it’s time’ for a wealth tax hike on ‘ultra-millionaires’ Mar 3, 05:47